Kyoto Unv.
Kyoto Unv. Hospital
　
　 HOME ご挨拶 外来診療 スタッフ紹介 アニュアルレポート 研究･業績 がん研修
　


２０１１年
２０１０年
２００９年
２００８年
２００７年
２００６年
２００５年
２００４年
２００３年


２０１１年

  1. K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura,S. Ohno, N. Masuda, H. Iwata, K. Aogi, K. Kuroi,M. Toi, Japan Breast Cancer Research Group (JBCRG): Correlation between docetaxel-induced skin toxicity and the use of steroids and H2 blockers: a multi-institution survey Breast Cancer Res Treat 未掲載: -, 2011.
  2. Takuwa H, Ueno T, Ishiguro H, Mikami Y, Kanao S, Takada M, Sugie T, Toi M.: A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy. Breast Cancer. 未掲載: -, 2011.
  3. Kanai M, Yoshimura K, Tsumura T, Asada M, Suzuki C, Niimi M, Matsumoto S, Nishimura T, Nitta T, Yasuchika K, Taura K, Mori Y, Hamada A, Inoue N, Tada S, Yanagihara K, Yazumi S, Osaki Y, Chiba T, Ikai I, Fukushima M, Uemoto S, Hatano E.: A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 67(6): 1429-1434, 2011.
  4. Kanai M, Yoshimura K, Asada M, Imaizumi A, Suzuki C, Matsumoto S, Nishimura T, Mori Y, Masui T, Kawaguchi Y, Yanagihara K, Yazumi S, Chiba T, Guha S, Aggarwal BB.: A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol 68(1): 157-164, 2011.
  5. Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T.: Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother Pharmacol. 未掲載: -, 2011.
  6. Alaboudy AA, Elbahrawy A, Matsumoto S, Yoshizawa A.: Conventional narrow-band imaging has good correlation with histopathological severity of Helicobacter pylori gastritis. Dig Dis Sci. 56（4）: 1127-1130, 2011.
  7. Ali AM, Ueno T, Tanaka S, Takada M, Ishiguro H, Abdellah AZ, Toi M.: Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients. Eur J Cancer. 未掲載: -, 2011.
  8. Takeda K, Kanao S, Okada T, Ueno T, Toi M, Ishiguro H, Mikami Y, Tanaka S, Togashi K.: MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy. Eur J Radiol. 未掲載: -, 2011.
  9. Nagai H, Tanaka S, Niimi M, Seo N, Sasaki T, Date H, Mishima M, Yasuda H, Yanagihara K.: Safety of erlotinib treatment in outpatients with previously treated non-small-cell lung cancer in Japan. Int J Clin Oncol. 未掲載: -, 2011.
  10. Tanaka S, Sakamori Y, Niimi M, Hazama M, Kim YH, Yanagihara K.: Design paper: A phase II study of Bevacizumab and Erlotinib in patients with non-Squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous Treatment (BEST). Trials. （Free PMC Article） 12: 120-120, 20
  11. 八田 太一, 成田 慶一, 柳原 一広, 石黒 洋, 岸本 寛史, 林 晶子, 猪原 登志子, 南 学, 村山 敏典, 横出 正之． 医療に関する達成動機尺度の開発～がん医療インフォーム ド・コンセントの観察研究にむけて～. 心身医学 2011, 51:73-79.

トップへ戻る


２０１０年

  1. Kanai M, Matsumoto S, Nishimura T, Matsumura Y, Hatano E, Mori A, Masui T, Kawaguchi Y, Nakamura E, Tada S, Kitano T, Ishiguro H, Yanagihara K, Chiba T.: Premedication with 20mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy Annals of Oncology 21(1): 189-190, 2010.
  2. Yanagihara K, Yoshimura K, Niimi M, Yasuda H, Sasaki T, Nishimura T, Ishiguro H, Matsumoto S, KitanoT, kanai M, Misawa A, Tada H, Teramukai S, Fukushima M.: PhaseⅡ study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer Cancer Chemother Pharmacol 66(5): 913-918, 2010.
  3. Kanai M, Yoshioka A, Tanaka S, Nagayama S, Matsumoto S, Nishimura T, Niimi M, Teramukai S, Takahashi R, Mori Y, Kitano T, Ishiguro H, Yanagihara K, Chiba T, Fukushima M, Fumihiko M.: Association between glutathione S-transferase Πlle105 Val and glyoxylate aminotransferase Pro11 Leu and lle340 Met polymorphisms and early-onset oxaliplatin-induced neuropathy Cancer Epidemiology 34(2): 189-193, 2010.
  4. Minami M, Matsumoto S, Horiuchi H: Cardiovascular Side-Effects of Modern Cancer Therapy Circ J 74: 1779-1786, 2010.
  5. Ishiguro H, Kondo M, Shu-Ling Hoshi, Takada M, Nakamura S, Teramukai S, Yanagihara K, Toi M: Economic Evaluation of Intensive Chemotherapy With Prophylactic Granulocyte Colony-Stimulating Factor for Patients With High-Risk Early Breast Cancer in Japan Clinical Therapeutics 32(2): 311-326, 2010.
  6. Wei D, Wang L, Kanai M, Jia Z, Le X, Li Q, Wang H, Xie K.: KLF4α up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology. 139(6): 2135-2145, 2010.
  7. Wei D, Wang L, Kanai M, Jia Z, Le X, Li Q, Wang H, Xie K.: KLF4α up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology. 139(6): 2135-2145, 2010.
  8. Takahashi R, Nagayama S, Mori Y, Isoda H, Yoshizawa A, Manabe T, Sakai Y.: A large cystic gastrointestinal stromal tumor of the rectum in the retrorectal space. Int J Clin Oncol. 15(6): 601-607, 2010.
  9. Nishizawa M, Nakamoto Y, Suga T, Kitano T, Ishikawa T, Yamashita K.: (11)C-Methionine PET/CT for multiple myeloma. Int J Hematol. 91(5): 733-734, 2010.
  10. Toi M, Ohashi Y, Seow A, Moriya T, Tse G, Sasano H, Park BW, Chow LW, Laudico AV, Yip CH, Ueno E, Ishiguro H, Bando H.: The Breast Cancer Working Group presentation was divided into three sections: the epidemiology, pathology and treatment of breast cancer. Jpn J Clin Oncol. 40(Suppl1): i13-18, 2010.
  11. Okuchi Y, Nagayama S, Mori Y, Kawamura J, Matsumoto S, Nishimura T, Yoshizawa A, Sakai Y.: VEGF hypersecretion as a plausible mechanism for pseudo-meigs' syndrome in advanced colorectal cancer. Jpn J Clin Oncol.? 40(5): 476-481, 2010.
  12. Mori Y, Nishimura T, Kitano T, Yoshimura K, Matsumoto S, Kanai M, Hazama M, Ishiguro H, Nagayama S, Yanagihara K, Teramukai S, Chiba T, Sakai Y, Fukushima M.: Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX. Oncology 79(1-2): 136-143, 2010.
  13. 三沢あき子、足立壮一、高島幸恵、小谷昌代、柳原一広: 小児外来化学療法における他児同室での保護者同伴静脈穿刺処置に関する調査研究 小児がん 47(1): 79-83, 2010.

トップへ戻る


２００９年

  1. Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, Minato K, Mio T, Fujita Y, Yonei T, Nakano K, Tsuboi M, Shibata K, Furuse K, Fukushima M: Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer.? 45(11): 1950-1958, 2009.
  2. Ishiguro H, Yano I, Toi M: Important Drug Interactions for Clinical Oncologists Frontiers in Drug Design & Discovery 4: 97-121, 2009.
  3. Ishiguro H, Yano I, Toi M: Pharmacogenomic Considerations in Breast Cancer Management Frontiers in Drug Design & Discovery 4: 122-134, 2009.
  4. Yasuda H, Nakayama K, Sasaki T, Yanagihara K.: Fas signal and cancer progression. Immunotherapy. 1(3): 337, 2009.
  5. Yasuda H, Nakayama K, Sasaki T, Yanagihara K.: Nitric oxide and cancer immunity in solid tumor tissues. Immunotherapy. 1(3): 338, 2009.
  6. Yasuda H, Nakayama K, Sasaki T, Yanagihara K.: Dual antibody plus chemotherapy in metastatic colorectal cancer. Immunotherapy. 1(3): 339-340, 2009.
  7. Onoue M, Terada T, Kobayashi M, Katsura T, Matsumoto S, Yanagihara K, Nishimura T, Kanai M, Teramukai S, Shimizu A, Fukushima M, Inui K.: UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japan cancer patients Int Clin Oncol 14(2): 136-142, 2009.
  8. Okoshi K, Nagayama S, Furu M, Mori Y, Yoshizawa A, Toguchida J, Sakai Y.: A case report of pathologically complete response of a huge rectal cancer after systemic chemotherapy with mFOLFOX6. Jpn J Clin Oncol. 39(8): 528-533, 2009.
  9. 祝千佳子、小林政彦、寺田智祐、矢野育子、松本繁巳、柳原一広、福島雅典、乾賢一: 外来化学療法部におけるＴＳ－１服用患者に対する継続的な薬学管理 医療薬学 35(12): 866-874, 2009.
  10. 山本景一、松本繁巳、柳原一広、手良向聡、福島雅典: 電子カルテシステムと臨床研究の連携：現状と実現のための要件 映像情報メディカル 41(5): 505-510, 2009.
  11. 柳原一広: 外来化学療法施行にあたって-外来化学療法室の整備 消化器の臨床 12(6): 615-620, 2009.
  12. 岡村みや子、高橋一栄、丸山志穂子、古俵孝明、池見泰明、祝千佳子、深津祥央、小林政彦、寺田智祐、柳原一広、乾賢一: エルロチニブ服用患者に対する外来調剤室での服薬指導体制の確立と今後の課題 日本病院薬剤師会雑誌 45(10): 1347-1351, 2009.
  13. 石黒洋: 化学療法副作用情報室：遅発性悪心・嘔吐対策 Cancer　Board乳癌 2(1): 56-58, 2009.
  14. 石黒洋: 化学療法副作用情報室：発熱性好中球減少の治療 Cancer　Board乳癌 2(2): 130-132, 2009.
  15. 南　博信、Stephan Zbinden、石黒洋: 乳癌の抗癌薬治療における心毒性 Cancer　Board乳癌 2(2): 144-151, 2009.
  16. 石黒洋: On going clinical study:JBCRG-M01 Cancer　Board乳癌 2(2): 153-, 2009.
  17. 藤澤浩美、橋田亨、寺田智祐、桂敏也、石黒洋、芳林浩史、乾賢一: 乳がん化学療法FEC100におけるG-CSF製剤の使用評価 医療薬学 35: 31-36, 2009.
  18. 北澤文章、寺田智祐、高橋一栄、松本繁巳、乾賢一: ベバシズマブの抗腫瘍効果に及ぼすレニン－アンジオデンシン系抑制薬の影響 医療薬学 35(5): 337-342, 2009.
  19. 石黒洋、越路みのり、森實敏夫、谷合央、夏江総太郎、藤本利夫、南部静洋: がん薬物療法に重要な薬物相互作用 癌と化学療法 36(5): 879-885, 2009.

トップへ戻る


２００８年

  1. Daoyan Wei, Kanai M, Zhiliang Jia, Xiangdong Le, and Keping Xie: ?Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res. 68(12): 4631-4639, 2008.
  2. Matsumoto S, Nishimura T, Kanai M, Mori Y, Nagayama S, Kawamura J, Nomura A, Miyamoto S, Kitano T, Ishiguro H, Yanagihara K, Teramukai S, Sakai Y, Chiba T, Fukushima M. : Safety and Efficacy of Modified FOLFOX6 for Treatment of Metastatic or Locally Advanced Colorectal Cancer.? Chemotherapy? 54(5): 395-403, 2008.
  3. Yagyu S, Gotoh T, Iehara T, Miyachi M, Katsumi Y, Tsubai-Shimizu S, Kikuchi K, Tamura S, Tsuchiya K, Imamura T, Misawa-Furihata A, Sugimoto T, Sawada T, Hosoi H: Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma Clin Cancer Res 14(21): 7011-7019, 2008.
  4. Nishida N, Nagasaka T, Nishimura T, Ikai I, C. Richard Boland, Ajay Goel: Aberrant Methylation of Multiple Tumor Suppressor Genes in Aging Liver, Chronic Hepatitis, and Hepatocellular Carcinoma. HEPATOLOGY 47(3): 908-918, 2008.
  5. Yamamoto　K, Matsumoto S, Tada H, Yanagihara K, Teramukai S, Takemura T, Fukushima M.: A data caputure system for outcomes studies that integrated with electronic health records: development and potential uses. J Med Syst? 32(5): 423-427, 2008.
  6. Osone S, Hosoi H, Tsuchiya K, Misawa A, Iehara T, Sugimoto T.: Low-dose protracted irinotecan as a palliative chemotherapy for advanced neuroblastoma. J Pediatr Hematol Oncol. 30(11): 853-856, 2008.
  7. Yamauchi J, Kanai M, Matsumoto S, Nishimura T, Yazumi S, Kami K, Kawaguchi Y, Yasuda H, Kitano T, Misawa A, Ishiguro H, Yoshikawa K, Yanagihara K, Fukushima M, Doi R, Chiba T.: Clincal outcome of combination therapy of gemcitabine with S-1 for advanced pancreatic cancer. Pancreas 36(3): 327-328, 2008.
  8. Nishimura T: Total Number of Genome Alterations in Sporadic Gastrointestinal Cancer Inferred from Pooled Analyses in the Literature.? Tumor Biol 29(6): 343-350, 2008.
  9. 柳原一広　松本繁巳　福島雅典: 京大病院外来化学療法部　がん診療支援システムの利用の実際 医薬の門 48(3): 66-70, 2008.
  10. 三宅知宏、橋田亨、小林政彦、寺田智祐、桂敏也、安田浩康、三尾直士、柳原一広、福島雅典、乾賢一: 肺がん患者に対する塩酸アムルビシンの外来化学療法における使用実態調査と血液毒性の評価 医療薬学 34(3): 268-273, 2008.
  11. 赤澤麻衣子、橋田亨、矢野育子、桂敏也、高島幸恵、手良向聡、松本繁巳、柳原一広、福島雅典、乾賢一: がん化学療法による悪心・嘔吐発現の性差 医療薬学 34(8): 742-747, 2008.
  12. 石黒洋: 化学療法副作用情報室：急性の悪心・嘔吐対策 Cancer　Board乳癌 1: 48-50, 2008.
  13. 高田正泰、石黒洋、戸井雅和: Breast and Endocrine Tumor 乳腺・内分泌腫瘍治療について 癌と化学療法 35: 2344-2350, 2008.
  14. 芳林浩史、石黒洋、高田正泰、竹内恵、山城大泰、上野貴之、加藤大典、吉川清次、金尾昌太郎、山内智香子、三上芳喜、戸井雅和: DocetaxelとCyclophosphamide併用術前化学療法が著効した乳癌の１例 癌と化学療法 35(6): 987-990, 2008.
  15. 石黒洋: Pharmacogenomics for Cancer Therapy:ホルモン療法のPharmacogenomics がん分子標的治療 6(3): 166-171, 2008.
  16. 山城大秦、石黒洋、戸井雅和: 妊娠中に発見された悪性腫瘍の取り扱い：妊娠中に発見される乳癌 産婦人科の実際 57: 669-675, 2008.
  17. 芳林浩史、石黒洋、戸井雅和: 補助化学療法・乳がんに対する補助薬物療法 腫瘍内科 2: 500-509, 2008.
  18. 松本　繁巳: 胃癌治療法　-現状・動向・評価-併用療法　CPT-11との併用療法　CPT-11+CDDP 日本臨床 66(5): 395-399, 2008.

トップへ戻る


２００７年

  1. Yasuda H, Kaneta T, Takai Y, Nakayama K, Iwata R, Tsujitani M, Takahashi S, Yamada S, Sasaki T, Yanagihara K, Yamaya M: Tumor hypoxia imaging with［F-18］fluoronitroimidazole in non-small-cell lung cancer.? J Am Geriatr Soc 55(7): 1142-1144, 2007.
  2. Miyamoto K, Shimizu K, Matsumoto S, Sumida H, Iida H, Hosoe H.: Surgical treatment of scoliosis associated with central core disease: minimizing the effects of malignant hyperthermia with provocation tests. J Pediatr Orthop B 16(3): 239-242, 2007.
  3. Hosoi H, Iehara T, Tsuchiya K, Misawa A, Miyaji M, Yagyu S, Koizumi M, Nishimura T, Tokiwa K, Iwai N, Yanagisawa A, Sugimoto T: Continuous Remission in an Infant with Chest Wall Malignant Rhabdoid Tumor after Relapse.? J Pediatr Surg 42(10): e9-e12, 2007."
  4. Sonobe M, Nakagawa M, Takenaka K, Katakura H, Adachi M, Yanagihara K, Otake Y, Wada H, Tanaka F: Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.? J Surg Oncol 95(1): 63-69, 2007.
  5. Mino N, Takenaka K, Sonobe M, Miyahara R, Yanagihara K, Otake Y, Wada H, Tanaka F: Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer. J Surg Oncol 95(3): 250-257, 2007.
  6. Sugino Y, Misawa A, Inoue J, Kitagawa M, Hosoi H, Sugimoto T, Imoto I, Inazawa J: Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas.? Oncogene? 26(53): 7401-7413, 2007.
  7. Tetsuo I, Tanaka E, Kadowaki T, Kan T, Higashiyama M, Shiojima S, Tomoda S, Myoumoto A, Akiyama H, Nobumasa H, Matsumoto S, Miyamoto S, Mitsumori M, Sato F, Watanabe G, Itami A, Stephan J.Meltzer, Tsujimoto G, Shimada Y: An Ultrasensitive New DNA Microarray Chip Provides Gene Expression Profiles for Preoperative Esophageal Cancer Biopsies without RNA Amplification. Oncology 73(5,6): 366-375, 2007.
  8. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M.: The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer.? Oncology? 73(3,4): 215-220, 2007.
  9. 柳原一広: 京都大学医学部付属病院外来化学療法部の展望 医学のあゆみ 222(13): 1113-1116, 2007.
  10. 山本景一、松本繁巳、松葉尚子、多田春江、松山晶子、柳原一広、手良向聡、福島雅典: 電子カルテ二次利用臨床研究用データ収集システムの開発と展望 医療情報学 27(2): 211-218, 2007.
  11. 寺田智祐、尾上雅英、小林政彦、松本繁巳、柳原一広、福島雅典、乾賢一: 新たな薬剤師業務展開としてのUGT1A1遺伝子解析 医療薬学 33(10): 858-862, 2007.
  12. 石黒洋、柳原一広: 外来化学療法と副作用対策：入院化学療法から外来化学療法へ 腫瘍内科 1(3): 213-218, 2007.
  13. 三沢あき子、足立壮一、梅田雄嗣、平松英文、渡邉健一郎、松本繁巳、柳原一広、細井創、杉本徹、中畑龍俊: 我が国における小児がん外来化学療法の診療 日本小児科学会雑誌 111(4): 550-555, 2007.
  14. 安田浩康、中山勝敏、山谷睦雄、浅田成紀、佐々木陽彦、柳原一広: 進行非小細胞肺癌における抗癌剤とニトログリセリン併用療法の個別化医療への展望 分子呼吸器病 11(2): 181-188, 2007.
  15. 嶋田裕、松本繁巳、森田周子、王孔志、森川司朗、藤本治郎: 食道の腫瘍性疾患　胸部早期食道癌 外科治療 96(suppl): 399-405, 2007.

トップへ戻る


２００６年

  1. Okumura T, Tsunoda S, Mori Y, Ito T, Kikuchi K, Wang TC, Yasumoto S, Shimada Y.: The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma. Clin Cancer Res. 12(17): 5096-5103, 2006.
  2. Kanai M, Daoyan Wei, Qiang Li, Zhiliang Jia, Jaffer Ajani, Xiangdong Le, James Yao, and Keping Xie: Loss of Kruppel-like Factor 4 Expression Contributes to Sp1 Overexpression and Human Gastric Cancer Development and Progression Clin Cancer Res. 12(21): 6395-6402, 2006.
  3. Yasuda H, Nakayama K, Watanabe M, Suzuki S, Fuji H, Okinaga S, Kanda A, Zayasu K, Sasaki T, Asada M, Suzuki T, Yoshida M, Yamanda S, Inoue D, Kaneta T, Kondo T, Takai Y, Sasaki H, Yanagihara K, Yamaya M: Nitroglycerin Treatment May Enhance Chemosensitivity to Docetaxel and Carboplatin in Patients with Lung Adenocarcinoma Clinical Cancer Research 12(22): 6748-6757, 2006.
  4. Yoshida Y, Kishimoto T, Ishiguro H, Nagai Y, Koda K, Takiguchi N, Miyazaki M, Ishikura H: Dexamethasone modifies the susceptibility to serum cytotoxicity and increases the metastatic efficiency of a colon carcinoma cell line. Experimental and Molecular Pathology: 81(1): 77-84, 2006.
  5. Nakayama S, Kanbara Y, Nishimura T, Nishida N, Hanioka K, Morita M, Fujita M, Sakurai K, and Hayashi Y: J Genome-wide microsatellite analysis of focal nodular hyperplasia: a strong tool for the differential diagnosis of non-neoplastic liver nodule from hepatocellular carcinoma.? Hepatobiliary Pancreat Surg. 13(5): 416-420, 2006.
  6. Ohashi S, Yazumi S, Watanabe N, Matsumoto S, Fukui T, NishioA and Chiba T: Gastrointestinal: MALT lymphoma of the terminal ileum. J Gastroenterol Hepatol 21(9): 1495-1495, 2006.
  7. Kiba T, Nishimura T, Matsumoto S, Hatano E, Mori A, Yasumi S, Doi R, Ikai I, Kitano T, Nishimura T, Yoshikawa K, Ishiguro H, Yanagihara K, Doi E Teramukai S, Fukushima M.: Single agent gemcitabine for biliary tract cancers with systematic review of literature.? Oncology 70(5): 358-365, 2006.
  8. Mori Y, Okumura T, Tsunoda S, Sakai Y,Shimada Y: Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma Oncology 70(5): 378-389, 2006.
  9. 赤澤麻衣子、橋田亨、矢野育子、桂敏也、北野俊行、植野正也、松本繁巳、柳原一広、福島雅典、乾賢一: 外来化学療レジメンの登録と処方支援機能の有用性. 医療薬学 32(4): 327-333, 2006.
  10. 金井雅史、石黒洋、松本繁巳: 化学療法中の患者でみられる下痢・便秘 medicina 43(13): 2057-2059, 2006.
  11. 石黒洋、南部静洋、前川陽子、安達進: 科学的根拠に基づいた悪心と嘔吐の対処法. 癌と化学療法 33(5): 701-706, 2006.
  12. 吉川清次、菅典道、加藤大典、三瀬圭一、森口喜生、山城大泰、石黒洋、児玉宏、稲本俊: HER2陽性転移性乳癌におけるハーセプチンを含む集学的治療後CR症例の検討. 癌治療と宿主 18(1): 91-91, 2006.
  13. 森本佳子、三沢あき子、木原美奈子、中島文明: アデノウイルス2型感染症を契機に全身型若年性特発性関節炎を発症した1例. 小児科診療 69(1): 125-128, 2006.

トップへ戻る


２００５年

  1. Ishikawa S, Nakagawa T, Miyahara R, Kawano Y, Takenaka K, Yanagihara K, Otake Y, Kataura H, Wada H, Tanaka F: Expression of MDA-7/IL-24 and Its Clinical Significance in Resected Non-Small Cell Lung Cancer (NSCLC). Clin Cancer Res 11(3): 1198-1202, 2005.
  2. Hirashiki K, Kishimoto T, Ishiguro H, Nagai Y, Furuya M, Sekiya S, Ishikura H: Regulatory role of CCAAT/enhancer binding protein-h in the production of plasma proteins in yolk sac tumor Experimental and Molecular Pathology 78(3): 247-256, 2005.
  3. Hasegawa S, Matsumoto S, Kawashima K, Fujii H, Hatano E, Satoh S, Ikai I, Shimahara Y.: [Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer] Gan To Kagaku Ryoho. 32(7): 1045-1049, 2005.
  4. Nishimura T, Nishida N, Itoh T, Komeda T, Fukuda Y, Ikai I, Yamaoka Y, Nakao K: Discrete Breakpoint and the Shortest Region of Overlap of Chromosome Arm 1q Gain and 1p Loss in Human Hepatocellular Carcinoma Detected by Semiquantitative Microsatellite Analysis. Genes Chromosomes Cancer 42(1): 34-43, 2005.
  5. Kanai M, Torii A, Hamada A, Endo Y, Takeda Y, Yamakawa M, Hikita H, Nishikawa H, Ochi J, Miura K, Noguchi M, Kashu I,? Sakurai T: Pure gastric yolk sac tumor that was diagnosed after curative resection:case report and review of litereture. Int J Gastrointestinal Cancer 35(1): 77-82, 2005.
  6. Iida H, Sumi K, Takenaka M, Asano T, Matsumoto S, Iwama T, Dohi S.: Periorbital pain associated with hemifacial spasms that responded to botulinum toxin treatment and microvascular decompression surgery: a case report. J Clin Anesth. 17(5): 363-365, 2005.
  7. Mamede M, Higashi T, Kitaichi M, Ishizu K, Ishimori T, Nakamoto Y, Yanagihara K, Li M, Tanaka F, Wada H, Manabe T, Saga T: [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia? 7(4): 369-379, 2005.
  8. Shimada Y, Watanabe G, Kawamura J, Soma T, Okabe M, Ito T, Inoue H, Kondo M, Mori Y, Tanaka E, Imamura M.: Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers. Oncology.? 68(2-3): 285-292, 2005.
  9. Shimada Y, Ando S, Matsunaga T, Misawa A, Aizawa T, Shirahata T, Itoi E.: Clinical application of acceleration sensor to detect the swing phase of stroke gait in functional electrical stimulation. Tohoku J Exp Med. 207(3): 197-202, 2005.
  10. 大谷佳代子、橋田亨、祝千佳子、大塚哉、尾上雅英、尾崎順子、石津雅弘、矢野育子、北野俊行、植野正也、松本繁巳、柳原一広、福島雅典、乾賢一: 外来化学療法部開設に伴う抗癌剤投与の安全管理システムの確立 医療薬学 31(4): 301-306, 2005.
  11. 西村貴文、柳原一広、松本繁巳、北野俊行、石黒洋、三沢あき子、木場崇剛、吉川清次、佐藤まなみ、中田和美、高島幸恵、亀野薫、橋田亨、福島雅典: 京都大学医学部付属病院の外来化学療法 癌と化学療法 32(13): 2150-2151, 2005.
  12. 石黒洋: がんの悪疫質は、サイトカインによる骨格筋遺伝子の選択的調節によって起こっている． Mebio Oncology 2(3): 110-111, 2005.
  13. 長谷川傑、松本繁巳、川島和彦、藤井英明、波多野悦朗、佐藤誠二、猪飼伊和夫、嶌原康行: 大腸癌肝転移症例に対する経口Leucovorin (Uzel)-UFT/肝動注併用療法の試み． 癌と化学療法 32(7): 1045-1049, 2005.

トップへ戻る


２００４年

  1. Ogasawara M, Kanai M, Tada E, Oe K, Hamada A, Endo Y, Yamakawa M, Takeda Y, Torii A, Hikita H, Matsubayashi Y, Nishikawa H, Ochi J, Miura K.: A case of effective weekly paclitaxel administration for primary lesion of schirrous gastric cancer Gan To Kagaku Ryoho.? 31(1): 91-93, 2004.
  2. Yamaoka S, Miyaji M, Kitano T, Umehara H, Okazaki T.: Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells. J Biol Chem. 279(18): 18688-18693, 2004.
  3. Ito T, Nishida N, Fukuda Y, Nishimura T, Komeda T and Kazuwa Nakao1: Alteration of the p14ARF gene and p53 status in human hepatocellular carcinomas.? J Gastroenterol 39(4): 355-361, 2004.
  4. Misawa A, Hosoi H, Imoto I, Iehara T, Sugimoto T, Inazawa J: Translocation (1;22) (p36;q11.2) with concurrent del(22) (q11.2) resulted in homozygous deletion of SNF5/INI1 in a newly established cell line derived from extrarenal rhabdoid tumor. Journal of Human Genetics 49(10): 586-589, 2004.
  5. Nakagawa T, Otake Y, Yanagihara K, Miyahara R, Ishikawa S, Fukushima M, Wada H, Tanaka F: Expression of thymidylate synthase is correlated with proliferative activity in non-small cell lung cancer (NSCLC). Lung Cancer 42(2): 145-149, 2004.
  6. Tanami H, Imoto I, Hirasawa A, Yuki Y, Sonoda I, Inoue J, Yasui K, Misawa-Furihata A, Kawakami Y, Inazawa J: Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.? Oncogene 23(54): 8796-8804, 2004.
  7. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, Sekikawa A, Kawada M, Suzuki K, Kayahara T, Fukui H, Sawada M, Chiba T.: STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene. 23(28): 4921-4929, 2004.
  8. 柳原一広、松本繁巳、植野正也、北野俊行、木場崇剛、三沢あき子、佐藤まなみ、藤田千恵子、橋田亨、福島雅典: 外来化学療法の展望と京都大学医学部付属病院外来化学療法部の紹介 医薬の門 44(5): 76-81, 2004.
  9. 上林孝豊、石橋修、柳原一広、田中文啓、長谷川誠紀、和田洋巳: 症状緩和と抗腫瘍効果にGefitinibが有効であったPS3進行期肺癌症例の1例． 癌と化学療法 31(2): 223-226, 2004.
  10. 芦田佳代子、橋田亨、祝千佳子、大塚哉、尾上雅英、尾崎淳子、石津雅弘、矢野育子、松本繁巳、柳原一広、福島雅典、乾賢一: 外来化学療法部開設に伴う抗癌剤投与の安全管理システムの確立 日本薬学会年会誌要旨集 124: ？-？, 2004.
  11. 伊東真哉、柳原一広、長谷川誠紀、和田洋巳: 気道狭窄に対するSelf-Expanding Nitinol Stentの長期成績と問題点 日本気管支学会雑誌 26(2): 145-148, 2004.
  12. "陳豊史、竹中一正、柳原一広、田中文啓、和田洋巳: 非小細胞肺癌におけるFlt-4陽性脈管密度（ＦＶＤ）の臨床的検討 日本胸部外科学会誌 52
  13. Supplement: 547-548, 2004."
  14. 田中文啓、竹中一正、柳原一広、和田洋巳: 非小細胞肺癌に対する術後補助療法：肺癌の診療ガイドラインは新たなエビデンスに基づいて早急に改訂すべきである 肺癌 44(4): 209-212, 2004.
  15. 松本繁巳、千葉勉: 内視鏡的粘膜切除術の適応拡大－高齢者． Mebio 21(4): 93-99, 2004.
  16. 松本繁巳、千葉勉: 食道癌診断・治療の最前線　総論２．　食道癌の疫学． モダンフィジシャン 24(1): 434-435, 2004.

トップへ戻る

２００３年

  1. Tanaka F, Oyanagi H, Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, Kawano Y, Li M, Otake Y, Wada H.: Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer. Cancer Res? 63(20): 6791-6794, 2003.
  2. Itoh M, Kitano T, Watanabe M, Kondo T, Yabu T, Taguchi Y, Iwai K, Tashima M, Uchiyama T, Okazaki T.: Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia. Clin Cancer Res. 9(1): 415-423, 2003.
  3. Yazumi S, Takahashi R, Kajiyama T, Nakase H, Watanabe N, Ohana M, Matsumoto S, Seno H, Sawada M, Uchida K, Nabeshima M, Okazaki K and Chiba T: Comparison of histological analysis and endosonographic features in esophageal granular cell tumors.? Digestive endoscopy 15: 284-288, 2003.
  4. Misawa A, Hosoi H, Tsuchiya K, Sugimoto T.: Rapamycin inhibits proliferation of human neuroblastoma cells without suppression of MycN. Int J Cancer. 104(2): 233-237, 2003.
  5. Hasegawa S, Bando T, Isowa N, Otake Y, Yanagihra K, Tanaka F, Inui K, Wada H: The use of cardiopulmonary bypass during extended resection of non-small cell lung cancer Interactive Cardiovascular and Thoracic Surgery?? 2(4): 676-679, 2003.
  6. Iwai K, Kondo T, Watanabe M, Yabu T, Kitano T, Taguchi Y, Umehara H, Takahashi A, Uchiyama T, Okazaki T.: Ceramide increases oxidative damage due to inhibition of catalase by caspase-3-dependent proteolysis in HL-60 cell apoptosis. J Biol Chem.? 278(11): 9813-9822, 2003.
  7. Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, Ishikawa S, Wada H: Correlation between apoptotic index and angiogenesis in non-small cell lung cancer: camparison between CD105 and CD34 as a marker of angiogenesis Lung Cancer 39(3): 289-296, 2003.
  8. Kanai M, Konda Y, Nakajima T, Izumi Y, Kanda N, Nanakin A, Kubohara Y, Chiba T.: Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway. Oncogene.? 22(4): 548-554, 2003.
  9. Misawa A, Hosoi H, Tsuchiya K, Iehara T, Sawada T, Sugimoto T.: Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation. Pediatr Hematol Oncol.? 20(2): 151-155, 2003.
  10. Shimada Y, Chida S, Matsunaga T, Misawa A, Ito H, Sakuraba T, Sato M, Hatakeyama K, Itoi E.: Grasping power by means of functional electrical stimulation in a case of C6 complete tetraplegia. Tohoku J Exp Med. 201(2): 91-96, 2003.
  11. 上林孝豊、李美於、柳原一広、宮原亮、板東徹、長谷川誠紀、乾健二、和田洋巳: CarboplatinとPaclitaxelの毎週投与が著効した気管支扁平上皮癌の1例 癌と化学療法 30(6): 841-844, 2003.

トップへ戻る



　 リンク │ サイトマップ
(c) Outpatient Oncology Unit, Kyoto University Hospital All Rights Reserved.


　

　
　

*--お願い--*
セカンドオピニオン
については
地域医療連携室
（075）751- 3110
に お問い合わせ ください。
診療予約について